BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24347169)

  • 1. Ninjurin1 deficiency attenuates susceptibility of experimental autoimmune encephalomyelitis in mice.
    Ahn BJ; Le H; Shin MW; Bae SJ; Lee EJ; Wee HJ; Cha JH; Lee HJ; Lee HS; Kim JH; Kim CY; Seo JH; Lo EH; Jeon S; Lee MN; Oh GT; Yin GN; Ryu JK; Suh JK; Kim KW
    J Biol Chem; 2014 Feb; 289(6):3328-38. PubMed ID: 24347169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
    Ahn BJ; Le H; Shin MW; Bae SJ; Lee EJ; Lee SY; Yang JH; Wee HJ; Cha JH; Seo JH; Lee HS; Lee HJ; Arai K; Lo EH; Jeon S; Oh GT; Kim WJ; Ryu JK; Suh JK; Kim KW
    J Biol Chem; 2014 Aug; 289(32):21926-36. PubMed ID: 24917672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling.
    Woo JK; Jang YS; Kang JH; Hwang JI; Seong JK; Lee SJ; Jeon S; Oh GT; Lee HY; Oh SH
    Oncotarget; 2016 May; 7(20):29592-604. PubMed ID: 27127177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal ectodomain of Ninjurin1 liberated by MMP9 has chemotactic activity.
    Ahn BJ; Le H; Shin MW; Bae SJ; Lee EJ; Wee HJ; Cha JH; Park JH; Lee HS; Lee HJ; Jung H; Park ZY; Park SH; Han BW; Seo JH; Lo EH; Kim KW
    Biochem Biophys Res Commun; 2012 Nov; 428(4):438-44. PubMed ID: 23142597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ninjurin1 regulates lipopolysaccharide-induced inflammation through direct binding.
    Shin MW; Bae SJ; Wee HJ; Lee HJ; Ahn BJ; Le H; Lee EJ; Kim RH; Lee HS; Seo JH; Park JH; Kim KW
    Int J Oncol; 2016 Feb; 48(2):821-8. PubMed ID: 26677008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ninjurin1 Is Up-regulated in Circulating Prostate Tumor Cells and Plays a Critical Role in Prostate Cancer Cell Motility.
    Park J; Joung JY; Hwang JE; Hong D; Park WS; Lee SJ; Lee KH
    Anticancer Res; 2017 Apr; 37(4):1687-1696. PubMed ID: 28373430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
    Lévesque SA; Paré A; Mailhot B; Bellver-Landete V; Kébir H; Lécuyer MA; Alvarez JI; Prat A; de Rivero Vaccari JP; Keane RW; Lacroix S
    J Exp Med; 2016 May; 213(6):929-49. PubMed ID: 27139491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
    Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
    J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
    Yacov N; Kafri P; Salem Y; Propheta-Meiran O; Feldman B; Breitbart E; Mendel I
    Clin Exp Immunol; 2020 Aug; 201(2):105-120. PubMed ID: 32353176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.
    Palazuelos J; Davoust N; Julien B; Hatterer E; Aguado T; Mechoulam R; Benito C; Romero J; Silva A; Guzmán M; Nataf S; Galve-Roperh I
    J Biol Chem; 2008 May; 283(19):13320-9. PubMed ID: 18334483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125a-5p attenuates macrophage-mediated vascular dysfunction by targeting Ninjurin1.
    Hwang SJ; Ahn BJ; Shin MW; Song YS; Choi Y; Oh GT; Kim KW; Lee HJ
    Cell Death Differ; 2022 Jun; 29(6):1199-1210. PubMed ID: 34974535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
    Ramroodi N; Khani M; Ganjali Z; Javan MR; Sanadgol N; Khalseh R; Ravan H; Sanadgol E; Abdollahi M
    Immunol Invest; 2015; 44(7):694-712. PubMed ID: 26436854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninjurin1 is expressed in myeloid cells and mediates endothelium adhesion in the brains of EAE rats.
    Ahn BJ; Lee HJ; Shin MW; Choi JH; Jeong JW; Kim KW
    Biochem Biophys Res Commun; 2009 Sep; 387(2):321-5. PubMed ID: 19595672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.